RxDoctor Payments Data

Max Greenky

Orthopaedic Surgery · Syracuse, NYNPI 1598151573

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (58.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Smith+Nephew at 54.0% of the total. Reporting peaked in 2021 at $15,333 and has fallen 95.0% since, to $764 in 2025.

$53,003in general payments, 2019–2025

Across 158 payments — averaging $335.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$29K
  • Lima USA, Inc.$9K
  • Liberty Surgical Inc.$5K
  • Depuy Synthes Products, Inc.$4K
  • Stryker$3K
  • Limacorporate S.p.a.$1K
  • plus $1K from 7 others

What the payments were for

  • Consulting fees$3,5557%
  • Travel & lodging$12,44823%
  • Food & beverage$6,21312%
  • Education$30,78758%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$53,003 in reported general payments places this provider in the 85th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$345,988
Medicare patients
778
Services billed
21,092

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naloxone Hcl76$5,788
EliquisApixaban12$5,344
Celecoxib171$2,025
Oxycodone Hcl215$1,356
Cephalexin76$628
Ketorolac Tromethamine67$562
Meloxicam281$509
Methylprednisolone46$335
Amoxicillin252$216
Azithromycin37$92
Ibuprofen11$54
Tramadol Hcl16$41

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Syracuse

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →